deltatrials
Recruiting OBSERVATIONAL NCT05906407

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (COGNITION)

COGNITION: Comprehensive Assessment of Clinical Features, Genomics and Further Molecular Markers to Identify Patients with Early Breast Cancer for Enrolment on Marker Driven Trials (Molecular Diagnostic Platform)

Sponsor: German Cancer Research Center

Updated 6 times since 2023 Last updated: Mar 17, 2025 Started: Apr 19, 2019 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Early-Stage Breast Cancer and Neoadjuvant Therapy, this trial is actively recruiting participants. The trial is conducted by German Cancer Research Center and has accumulated 6 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jul 2023 – ~Dec 2023 · 5 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Apr 2025 — Sep 2025 [monthly]

    Recruiting

  3. Sep 2024 — Apr 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Dec 2023 — Jul 2024 [monthly]

    Recruiting

Show 1 earlier version
  1. Jul 2023 — Dec 2023 [monthly]

    Recruiting

    First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Cancer Research Center
  • German Federal Ministry of Education and Research
  • University Hospital Heidelberg
Data source: German Cancer Research Center

For direct contact, visit the study record on ClinicalTrials.gov .